New Zealand Authorizes Controlled MDMA Access for PTSD
New Zealand has greenlit a restricted pathway for psychiatrists to prescribe pharmaceutical-grade MDMA to adult PTSD patients.
By The Herb House Desk·September 8, 2026

New Zealand has authorized two psychiatrists to prescribe pharmaceutical-grade MDMA for certain adults suffering from post-traumatic stress disorder. This initiative establishes a closely regulated treatment avenue, even as the substance maintains its unapproved status generally.
This development provides a structured, albeit limited, access point for MDMA therapy within the country's medical framework.
Source: High Times.
Reporting informed by public dispatches from High Times.